WO2023123309A1 - Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection - Google Patents

Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection Download PDF

Info

Publication number
WO2023123309A1
WO2023123309A1 PCT/CN2021/143530 CN2021143530W WO2023123309A1 WO 2023123309 A1 WO2023123309 A1 WO 2023123309A1 CN 2021143530 W CN2021143530 W CN 2021143530W WO 2023123309 A1 WO2023123309 A1 WO 2023123309A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
injection
amino acid
standard
diluent
Prior art date
Application number
PCT/CN2021/143530
Other languages
French (fr)
Chinese (zh)
Inventor
李泽南
桂王艳
高华
熊华萍
Original Assignee
浙江海正药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江海正药业股份有限公司 filed Critical 浙江海正药业股份有限公司
Priority to CN202180062287.9A priority Critical patent/CN117203524A/en
Priority to PCT/CN2021/143530 priority patent/WO2023123309A1/en
Publication of WO2023123309A1 publication Critical patent/WO2023123309A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers

Definitions

  • the invention relates to the technical field of quality control of a special solvent for ademetionine succinate for injection, in particular to a method for detecting amino acid impurities in a special solvent for ademetionine succinate for injection.
  • Adenosylmethionine is a physiologically active molecule present in all tissues and fluids of the human body. As a methyl donor (transmethylation) and a precursor of physiological sulfur compounds (such as cysteine, taurine, glutathione and coenzyme A, etc.) biochemical reactions. Freeze-dried powder for injection (adenosylmethionine succinate for injection) must be dissolved with the attached solvent before use, a special solvent for adenosylmethionine succinate for injection.
  • the special solvent for adenosylmethionine succinate for injection is a sterilized solution of L-lysine, and the content of L-lysine (C 6 H 14 N 2 O 2 ) in each tube (5ml) should be 385 ⁇ 450mg.
  • L-lysine C 6 H 14 N 2 O 2 .
  • Lysine is the basic unit of protein. It is the raw material for the synthesis of human hormones, enzymes and antibodies. It participates in human metabolism and various physiological activities. Lysine is an essential amino acid for the human body and is basically found in various amino acid infusion formulas.
  • L-lysine Most amino acids are obtained through fermentation process, and most of the impurities produced are other amino acids. According to the technological process of L-lysine, other amino acid impurities that may exist in L-lysine include phenylalanine, leucine, threonine and DL-aminocaprolactam hydrochloride, etc.
  • L-arginine in the special solvent for adenosylmethionine succinate for injection is detected. It uses thin-layer chromatography for limit detection rather than quantitative detection. After the sample solution climbs the plate of thin-layer chromatography and develops color with a chromogenic agent, it is visually detected, and the sensitivity is low.
  • the TLC method cannot detect the impurities of phenylalanine, leucine, threonine and DL-aminocaprolactam hydrochloride that may exist in the special solvent for adenosylmethionine succinate for injection.
  • Thin-layer chromatography needs to use more organic toxic developer and chromogenic reagent, and the cumbersome operation steps can introduce more experimental systematic errors, and it is difficult to achieve quantitative detection at lower concentrations. Therefore, it is necessary to develop a simple and reliable detection method to improve the existing impurity detection method.
  • the present invention changes the tedious detection steps of thin-layer chromatography detection, avoids the use of organic toxic reagents, and is a great benefit for researchers. A more wholesome approach, while allowing effective quality control of the amount of multiple amino acid impurities.
  • the main purpose of the present invention is to provide a method for detecting amino acid impurities in the special solvent for ademetionine succinate for injection, so as to solve the problem of amino acid impurities in the special solvent for adenosylmethionine succinate for injection in the prior art Problems that cannot be effectively quantified.
  • a method for detecting amino acid impurities in ademethionine succinate injection special solvent which is characterized in that it includes:
  • Step S1 Dissolving the standard substances of DL-aminocaprolactam, phenylalanine, leucine, and threonine in a diluent to obtain a standard solution;
  • Step S2 dissolving the special solvent for adenosylmethionine succinate for injection with a diluent to obtain a sample solution;
  • Step S3 Using high performance liquid chromatography-mass spectrometry to detect the standard solution obtained in step S1 and the sample solution obtained in step S2.
  • the amino acid impurities include: phenylalanine, leucine, DL-aminocaprolactam, threonine
  • the detection method includes: preparing standard solutions of various amino acid impurities; preparing sensitivity solutions; preparing samples to be tested, taking a special solvent for adenosylmethionine succinate for injection, diluting with a diluent to a certain concentration, and then mixing to obtain a sample solution;
  • the standard solution and the sample solution to be detected are detected by high performance liquid chromatography-mass spectrometry to obtain the characteristic ion peak area of each amino acid impurity; and the characteristic ion peak area and standard product detected according to the sample detection
  • the measured characteristic ion peak area is converted to obtain the impurities of each amino acid in the special solvent for adenosylmethionine succinate
  • the above-mentioned process of preparing the standard solution includes: weighing 5 mg each of phenylalanine, leucine, and threonine, and 6.4 mg of DL-aminocaprolactam hydrochloride (equivalent to 5 mg of DL-aminocaprolactam) In a 25ml volumetric flask, dissolve with diluent and make the volume up to the mark, and mix well to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain stock solution B.
  • the process of the above-mentioned sensitivity solution includes: pipetting 3.0ml of the above-mentioned standard solution, adding a diluent to dilute to 10ml, and mixing evenly.
  • the above-mentioned diluent is a mixed solution of methanol and water mixed at a volume ratio of 60:40.
  • the above-mentioned preparation of the sample to be tested includes: taking 1 bottle of adenosylmethionine dimethylsulfonate special solvent for injection (specification 5ml: 428mg), pipetting 0.4ml and diluting it to 10ml with a diluent, and mixing to obtain a sample stock solution. Pipette 0.6ml of sample stock solution, add diluent to dilute to 10ml, and mix to obtain sample solution. Use the diluent as a blank sample.
  • the concentration of DL-aminocaprolactam in the above sensitivity solution is 0.124 ⁇ g/ml
  • the concentration of leucine is 0.121 ⁇ g/ml
  • the concentration of phenylalanine is 0.120 ⁇ g/ml
  • the concentration of threonine is 0.117 ⁇ g /ml.
  • the prior art usually conducts a limit detection of one amino acid impurity in the special solvent for adenosylmethionine succinate for injection, but cannot quantitatively detect other amino acid impurities, which leads to inability to Effective quality control of other amino acid impurities.
  • the detection method of amino acid impurities in the special solvent for adenosylmethionine disulfonate includes: preparing a standard solution and a sensitivity solution; preparing a sample to be tested, taking the special solvent for adenosylmethionine butanedisulfonate for injection and diluting it with a diluent Dissolving to form a solution; the sample to be detected is detected by high performance liquid chromatography-mass spectrometry, and the mass chromatogram of the standard product of high performance liquid chromatography tandem mass spectrometry of amino acid impurities and the sample is obtained, according to the analysis of the mass chromatogram Results Determine the characteristic ion peaks of various amino acid impurities in the mass chromatogram, and calculate the mass
  • the high-performance liquid chromatography and mass spectrometry are used to test the special solvent for adenosylmethionine succinate for injection
  • the high performance liquid chromatography is used to separate the impurities in the special solvent for adenosylmethionine succinate for injection.
  • mass spectrometry carries out further detection to isolate and obtains corresponding mass chromatogram, utilizes mass chromatogram to determine the characteristic ion peak of amino acid impurity and amino acid impurity in corresponding chromatogram, according to this characteristic ion peak area and standard product peak area namely The mass content of amino acid impurities can be obtained.
  • the application uses mass spectrometry data to accurately correspond to the characteristic ion peaks of amino acid impurities in the mass chromatogram, thereby obtaining the accurate mass content of amino acid impurities , to provide a reliable data basis for the effective quality control of amino acid impurities.
  • the establishment of the standard curve in this application can refer to the process of establishing the standard curve commonly used in the liquid chromatography test in the prior art.
  • the above step S1 uses the solution of the amino acid impurity standard as the standard solution, preferably preparing the standard
  • the solvent of the solution is a diluent, preferably the diluent is a mixture of methanol and water, more preferably the volume ratio of methanol and water is 60:40.
  • amino acid impurities exist as impurities in the special solvent for adenosylmethionine succinate for injection, their content is relatively small.
  • the mass content of amino acid impurities in the above-mentioned standard solution is preferably 0.4 ⁇ g/mL. The reliability of the standard curve obtained by using the standard solution of the above concentration as the basis of the test is better.
  • the preferred diluent is a mixture of methanol and water, more preferably the volume ratio of methanol and water is 60:40.
  • the chromatographic column was a Poroshell 120 HILIC-Z chromatographic column, the column temperature was 30-40°C, and the flow rate was 0.8ml/min;
  • the mobile phase A is a mixed solution of acetonitrile and buffer solution according to the volume ratio of 95:5
  • mobile phase B is a mixed solution of acetonitrile and buffer solution according to the volume ratio of 50:50.
  • the elution mode of mobile phase is gradient elution, and described gradient elution procedure is:
  • the column temperature is 30°C.
  • the injection volume is 2ul.
  • the condition setting of the above-mentioned mass spectrometry detection preferably includes: the ion source is an electrospray ionization source (AJS ESI), the mass spectrometry detector is a triple quadrupole detector (QQQ), and the drying gas temperature is 300 ⁇ 350°C, drying gas flow rate is 9 ⁇ 11L/min, atomizing gas pressure is 50 ⁇ 55psi, sheath flow gas temperature is 360 ⁇ 390°C, sheath flow flow rate is 10 ⁇ 12L/min, capillary terminal voltage is 3000 ⁇ 4000V, The nozzle voltage was 450-550V, and the scanning mode was mass spectrometry multiple reaction monitoring (MRM).
  • MRM mass spectrometry multiple reaction monitoring
  • the condition settings for the above-mentioned mass spectrometry detection include: the ion source is an electrospray ion source (AJS ESI), the mass spectrometer detector is a triple quadrupole detector (QQQ), and the drying gas temperature is 350°C , the drying gas flow rate is 11L/min, the atomizing gas pressure is 55psi, the sheath gas temperature is 390°C, the sheath gas flow rate is 12L/min, the capillary terminal voltage is +3500V, the nozzle voltage is +500V, and the scanning mode is mass spectrometry multiple reaction Detection (MRM), the parameters are:
  • the present invention changes the cumbersome detection steps of thin-layer chromatography detection, avoids the use of organic and toxic developing agents and chromogenic agents, and is beneficial to For researchers, it is a more healthy method, and at the same time, it can effectively control the amount of multiple amino acid impurities. It solves the problem that amino acid impurities in the special solvent for adenosylmethionine succinate for injection in the prior art cannot be effectively quantified, and can detect each amino acid in the special solvent for adenosylmethionine succinate for injection by one method content of impurities.
  • the special solvent for adenosylmethionine succinate for injection of the present invention is a sterilized solution of L-lysine, and each (5ml) containing L-lysine (C 6 H 14 N 2 O 2 ) should be
  • L-lysine C 6 H 14 N 2 O 2
  • the chemical structure of L-lysine is as follows:
  • Fig. 1 is the total ion chromatogram of amino acid impurities in the standard solution
  • Fig. 2 is the multiple reaction monitoring extracted ion chromatogram of DL-aminocaprolactam in the standard solution
  • Fig. 3 is the MRM extraction ion chromatogram of leucine in standard solution
  • Fig. 4 is the MRM extraction ion chromatogram of phenylalanine in the standard solution
  • Fig. 5 is the MRM extraction ion chromatogram of threonine in the standard solution
  • Fig. 6 is the total ion chromatogram of amino acid impurities in the sample solution
  • Fig. 7 is the MRM extraction ion chromatogram of DL-aminocaprolactam in the sample solution
  • Figure 8 is an MRM-extracted ion chromatogram of leucine in the sample solution
  • Fig. 9 is the multiple reaction monitoring extracted ion chromatogram of phenylalanine in the sample solution
  • Figure 10 is the multiple reaction monitoring extracted ion chromatogram of threonine in the sample solution
  • Fig. 11 is DL-amino caprolactam standard curve
  • Figure 12 is a leucine standard curve
  • Fig. 13 is phenylalanine standard curve
  • Figure 14 is a threonine standard curve.
  • the special solvent for adenosylmethionine butyl disulfonate for injection is provided by Zhejiang Hisun Pharmaceutical Co., Ltd.
  • the detection conditions of the high-performance liquid chromatography-mass spectrometer involved in the following detection are:
  • the chromatographic column is a Poroshell 120 HILIC-Z chromatographic column
  • the injection volume is 2ul
  • the column temperature is 30°C
  • the flow rate is 0.8ml/min
  • the mobile phase A is acetonitrile and buffer solution according to The mixed solution of volume ratio 95:5
  • mobile phase B is the mixed solution of acetonitrile and buffer solution according to volume ratio 50:50
  • described buffer solution is the solution that 10mM ammonium formate aqueous solution adjusts pH to 3.0 with formic acid
  • the chromatographic column is a Poroshell 120 HILIC-Z chromatographic column
  • the elution mode of mobile phase is gradient elution, and described gradient elution procedure is:
  • the conditions for mass spectrometry detection were set as follows: the ion source was an electrospray ionization source (AJS ESI), the mass spectrometer detector was a triple quadrupole detector (QQQ), the drying gas temperature was 350 °C, the drying gas flow rate was 11 L/min, and the fog
  • the gas pressure is 55psi
  • the sheath gas temperature is 390°C
  • the sheath gas flow rate is 12L/min
  • the capillary end voltage is +3500V
  • the nozzle voltage is +500V
  • the scan mode is MRM
  • the parameters are:
  • the standard solution preparation process is as follows:
  • the standard solution is the system suitability solution: use a diluent to prepare 5 mg each of phenylalanine, leucine, and threonine, and 6.4 mg of DL-aminocaprolactam hydrochloride (equivalent to 5 mg of DL-aminocaprolactam).
  • a mixed standard solution with a concentration of 0.4 ⁇ g/ml was prepared.
  • the sensitivity solution preparation process is as follows:
  • the sample solution preparation process is as follows:
  • the detection conditions of the sample solution are the same as those of the standard solution.
  • a Spl the peak area of each amino acid in the sample solution
  • a Std the average peak area of each standard product in 6 needle standard product solutions
  • W Std the weighing amount of each standard in the standard solution, expressed in mg
  • V Std the dilution volume of each standard in the standard solution, expressed in ml;
  • Accuracy stock solution Weigh 4.822mg of phenylalanine, 5.040mg of leucine, 4.898mg of threonine, and 6.669mg of DL-aminocaprolactam hydrochloride in a 25ml volumetric flask, dissolve with diluent and Dilute to the mark and mix to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain the accuracy stock solution.
  • Sample stock solution Take 1 bottle of special solvent for adenosylmethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with diluent, and mix well to obtain the sample stock solution
  • 100% accuracy sample solution take 0.5ml accuracy stock solution and 0.6ml sample stock solution, dilute to 10ml with diluent, mix well, and get ready. Prepare 3 copies in parallel.
  • the linear stock solution is the same as the standard stock solution B above.
  • the correlation coefficient (R 2 ) is not less than 0.98
  • the interference of the blank solvent (mobile phase, diluent) in the retention time window of each amino acid shall not be greater than 10% of each standard solution. (Take certain measures when necessary)
  • Standard solution Weigh 5.001mg of phenylalanine, 5.033mg of leucine, 4.883mg of threonine, and 6.662mg of DL-aminocaprolactam hydrochloride in a 25ml volumetric flask, dissolve and set Make up to the mark and mix well to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain stock solution B.
  • the signal-to-noise ratio of each amino acid impurity in the 6-pin LOQ solution is ⁇ 10;
  • Sample solution Take 1 bottle of special solvent for adenosylmethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with a diluent, and mix well to obtain a sample stock solution. Pipette 0.6ml of sample stock solution, add diluent to dilute to 10ml, and mix to obtain sample solution.
  • the diluent is a mixed solvent of methanol and purified water at a volume ratio of 60:40. Sample solutions were prepared in parallel in duplicate.
  • Chromatographic analysis procedure After the chromatographic system of the instrument is balanced, inject a needle of sensitivity solution to check the signal-to-noise ratio, which is required to be not less than 10. Inject 6 needles of standard solution continuously, and calculate the average value and RSD of the peak areas of the 6 chromatograms of standard solution should not be greater than 10%; inject 1 needle for each sample solution. Inject no more than 8 needles and at the end of the sequence, respectively inject a needle of system adaptability solution. Compared with the first 6 needles of system adaptability solution continuously injected, the RSD of the peak area of amino acid impurities should not be greater than 10%.
  • the mass content of each impurity is obtained by using the external standard method and according to the mass chromatogram of each impurity of amino acid and the concentration and mass chromatogram of the standard solution, according to the above impurity calculation formula.
  • ND means that the detection result is less than LOD.
  • the LODs of the four impurities are all 0.03%.
  • This application has established a high-performance liquid chromatography-mass spectrometry method for tandem testing of amino acids in the special solvent for adenosylmethionine succinate for injection.
  • a unique chromatographic condition was adopted, including the components of the mobile phase and Separation and chromatographic procedures to separate the amino acid impurities in the special solvent for adenosylmethionine succinate for injection, and then further detect the isolates corresponding to each characteristic peak by mass spectrometry to obtain the corresponding mass chromatogram.
  • the figure can determine the amino acid impurities and the characteristic ion peaks of the amino acid impurities in the corresponding chromatogram.
  • the mass content of the amino acid impurities can be calculated according to the external standard method. It can be seen that, on the basis of realizing the sufficient separation of amino acid impurities by high performance liquid chromatography, the application uses mass spectrometry data to accurately correspond to the characteristic ion peaks of amino acid impurities in the mass chromatogram, thereby obtaining the accurate mass content of amino acid impurities , to provide a reliable data basis for the effective quality control of amino acid impurities.

Abstract

A method for measuring amino acid impurities in a special solvent for butanedisulfonic acid adenosine methionine for injection. The measurement method comprises: preparing a standard solution and a sensitivity solution of each amino acid impurity (DL-aminocaprolactam, phenylalanine, leucine, and threonine); preparing a sample to be measured: diluting a special solvent for butanedisulfonic acid adenosine methionine for injection with diluents into a solution having a certain concentration to form said sample, the diluents being methanol and purified water at a volume ratio of 60 : 40; preparing a mobile phase into a mobile phase A (5:95) and a mobile phase B (50:50) by using a buffer salt (the pH of 10mM ammonium formate being adjusted to 3.0 with formate acid) and acetonitrile according to a certain ratio; and carrying out sample measurement by using a high-performance liquid chromatography-mass spectrometer, so that the content of each amino acid impurity in the solvent special for the butanedisulfonic acid adenosine methionine for injection can be measured by the method.

Description

一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法A method for detecting amino acid impurities in adenosylmethionine succinate injection special solvent 技术领域technical field
本发明涉及注射用丁二磺酸腺苷蛋氨酸专用溶剂质量控制技术领域,具体而言,涉及一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法。The invention relates to the technical field of quality control of a special solvent for ademetionine succinate for injection, in particular to a method for detecting amino acid impurities in a special solvent for ademetionine succinate for injection.
背景技术Background technique
腺苷蛋氨酸是存在于人体所有组织和体液中的一种生理活性分子。它作为甲基供体(转甲基作用)和生理性硫基化合物(如半胱氨酸,牛磺酸,谷胱甘肽和辅酶A等)的前体(转硫基作用)参与体内重要的生化反应。注射用冻干粉针(注射用丁二磺酸腺苷蛋氨酸)须在临用前用所附溶剂溶解,一种注射用丁二磺酸腺苷蛋氨酸专用溶剂。Adenosylmethionine is a physiologically active molecule present in all tissues and fluids of the human body. As a methyl donor (transmethylation) and a precursor of physiological sulfur compounds (such as cysteine, taurine, glutathione and coenzyme A, etc.) biochemical reactions. Freeze-dried powder for injection (adenosylmethionine succinate for injection) must be dissolved with the attached solvent before use, a special solvent for adenosylmethionine succinate for injection.
注射用丁二磺酸腺苷蛋氨酸专用溶剂为L-赖氨酸的灭菌溶液,每支(5ml)中含L-赖氨酸(C 6H 14N 2O 2)应为385~450mg,L-赖氨酸的化学结构如下: The special solvent for adenosylmethionine succinate for injection is a sterilized solution of L-lysine, and the content of L-lysine (C 6 H 14 N 2 O 2 ) in each tube (5ml) should be 385~450mg. The chemical structure of L-lysine is as follows:
Figure PCTCN2021143530-appb-000001
Figure PCTCN2021143530-appb-000001
赖氨酸是构成蛋白质的基本单位,是合成人体激素、酶及抗体的原料,参与人体新陈代谢和各种生理活动,赖氨酸是人体必需氨基酸,在各种氨基酸输液配方中基本上都有。Lysine is the basic unit of protein. It is the raw material for the synthesis of human hormones, enzymes and antibodies. It participates in human metabolism and various physiological activities. Lysine is an essential amino acid for the human body and is basically found in various amino acid infusion formulas.
大多数氨基酸是通过发酵工艺得到,产生的杂质大多是其他氨基酸。根据L-赖氨酸的工艺过程,L-赖氨酸中可能存在的其他氨基酸类杂质包括苯丙氨酸、亮氨酸、苏氨酸和DL-氨基己内酰胺盐酸盐等。现有检测技术中只对注射用丁二磺酸腺苷蛋氨酸专用溶剂中的L-精氨酸进行检测。其采用薄层色谱法进行限度检测而非定量检测,样品溶液在薄层色谱爬板后,用显色剂显色后,目视检测,灵敏度低。且该薄层色谱法对注射用丁二磺酸腺苷蛋氨酸专用溶剂可能存在的苯丙氨酸、亮氨酸、苏氨酸和DL-氨基己内酰胺盐酸盐杂质不能进行检测。薄层色谱法需要用到较多的有机有毒展开剂和显色剂,操作步骤繁琐可引入更多实验的系统误差,且较难实现较低浓度的定量检测。因此有必要开发一种简便可靠的检测方法对现有杂质检测方法进行改进。本发明与现有的注射用丁二磺酸腺苷蛋氨酸专用溶剂中检测杂质的方法相比,改变了薄层色谱检测的繁琐的检测步骤,避免使用有机有毒试剂,对研究者而言是一种更加有益健康的方法,同时还能对多个氨基酸类杂质的量进行有效质量控制。Most amino acids are obtained through fermentation process, and most of the impurities produced are other amino acids. According to the technological process of L-lysine, other amino acid impurities that may exist in L-lysine include phenylalanine, leucine, threonine and DL-aminocaprolactam hydrochloride, etc. In the existing detection technology, only L-arginine in the special solvent for adenosylmethionine succinate for injection is detected. It uses thin-layer chromatography for limit detection rather than quantitative detection. After the sample solution climbs the plate of thin-layer chromatography and develops color with a chromogenic agent, it is visually detected, and the sensitivity is low. Moreover, the TLC method cannot detect the impurities of phenylalanine, leucine, threonine and DL-aminocaprolactam hydrochloride that may exist in the special solvent for adenosylmethionine succinate for injection. Thin-layer chromatography needs to use more organic toxic developer and chromogenic reagent, and the cumbersome operation steps can introduce more experimental systematic errors, and it is difficult to achieve quantitative detection at lower concentrations. Therefore, it is necessary to develop a simple and reliable detection method to improve the existing impurity detection method. Compared with the existing method for detecting impurities in adenosylmethionine succinate methionine special solvent for injection, the present invention changes the tedious detection steps of thin-layer chromatography detection, avoids the use of organic toxic reagents, and is a great benefit for researchers. A more wholesome approach, while allowing effective quality control of the amount of multiple amino acid impurities.
发明内容Contents of the invention
本发明的主要目的在于提供一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法,以解决现有技术中的注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质不能有效定量的问题。The main purpose of the present invention is to provide a method for detecting amino acid impurities in the special solvent for ademetionine succinate for injection, so as to solve the problem of amino acid impurities in the special solvent for adenosylmethionine succinate for injection in the prior art Problems that cannot be effectively quantified.
为了实现上述目的,根据本发明的一个方面,提供了一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法,其特征在于,包括:In order to achieve the above object, according to one aspect of the present invention, a method for detecting amino acid impurities in ademethionine succinate injection special solvent is provided, which is characterized in that it includes:
步骤S1:将DL-氨基己内酰胺、苯丙氨酸、亮氨酸、苏氨酸的标准品采用稀释剂溶解得到标准品溶液;Step S1: Dissolving the standard substances of DL-aminocaprolactam, phenylalanine, leucine, and threonine in a diluent to obtain a standard solution;
步骤S2:将注射用丁二磺酸腺苷蛋氨酸专用溶剂用稀释剂溶解得到样品溶液;Step S2: dissolving the special solvent for adenosylmethionine succinate for injection with a diluent to obtain a sample solution;
步骤S3:采用高效液相色谱-质谱联用仪对步骤S1得到的标准品溶液和步骤S2得到的样品溶液进行检测。Step S3: Using high performance liquid chromatography-mass spectrometry to detect the standard solution obtained in step S1 and the sample solution obtained in step S2.
进一步地,本发明的一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法,该氨基酸类杂质包括:苯丙氨酸、亮氨酸、DL-氨基己内酰胺、苏氨酸,检测方法包括:配制各氨基酸类杂质的标准品溶液;配制灵敏度溶液;配制待检测样品,取注射用丁二磺酸腺苷蛋氨酸专用溶剂用稀释剂稀释至一定浓度后混匀得样品溶液;样品检测,将所述标准品溶液和待检测样品溶液采用高效液相色谱-质谱联用仪进行检测,得到各氨基酸杂质的特征离子峰面积;以及根据样品检测得到的特征离子峰面积和标准品测到的特征离子峰面积,换算得到注射用丁二磺酸腺苷蛋氨酸专用溶剂中各氨基酸的杂质。Furthermore, a method for detecting amino acid impurities in a special solvent for adenosylmethionine succinate for injection of the present invention, the amino acid impurities include: phenylalanine, leucine, DL-aminocaprolactam, threonine The detection method includes: preparing standard solutions of various amino acid impurities; preparing sensitivity solutions; preparing samples to be tested, taking a special solvent for adenosylmethionine succinate for injection, diluting with a diluent to a certain concentration, and then mixing to obtain a sample solution; For sample detection, the standard solution and the sample solution to be detected are detected by high performance liquid chromatography-mass spectrometry to obtain the characteristic ion peak area of each amino acid impurity; and the characteristic ion peak area and standard product detected according to the sample detection The measured characteristic ion peak area is converted to obtain the impurities of each amino acid in the special solvent for adenosylmethionine succinate for injection.
进一步地,上述配制标准品溶液的过程包括:称取苯丙氨酸、亮氨酸、苏氨酸各5mg,DL-氨基己内酰胺盐酸盐6.4mg(相当于DL-氨基己内酰胺5mg)同置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀得储备液A。精密移取0.4ml储备液A于10ml容量瓶中,用稀释剂稀释至刻度,混匀得储备液B。精密移取0.5ml储备液B于10ml容量瓶中,用稀释剂稀释至刻度,混匀得苯丙氨酸、亮氨酸、苏氨酸、DL-氨基己内酰胺浓度均为0.4μg/ml的标准品溶液。Further, the above-mentioned process of preparing the standard solution includes: weighing 5 mg each of phenylalanine, leucine, and threonine, and 6.4 mg of DL-aminocaprolactam hydrochloride (equivalent to 5 mg of DL-aminocaprolactam) In a 25ml volumetric flask, dissolve with diluent and make the volume up to the mark, and mix well to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain stock solution B. Precisely pipette 0.5ml of stock solution B into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a standard with a concentration of 0.4μg/ml for phenylalanine, leucine, threonine, and DL-aminocaprolactam product solution.
进一步地,上述灵敏度溶液的过程包括:移取3.0ml上述标准品溶液,加稀释剂稀释至10ml,混匀即得。进一步地,上述稀释剂为甲醇和水以60:40的体积比混合的混合溶液。Further, the process of the above-mentioned sensitivity solution includes: pipetting 3.0ml of the above-mentioned standard solution, adding a diluent to dilute to 10ml, and mixing evenly. Further, the above-mentioned diluent is a mixed solution of methanol and water mixed at a volume ratio of 60:40.
进一步地,上述配制待检测样品包括:取1瓶注射用丁二磺酸腺苷蛋氨酸专用溶剂(规格5ml:428mg),移取0.4ml用稀释剂稀释至10ml,混匀得样品储备液。移取样品储备液0.6ml,加稀释剂稀释至10ml,混匀得样品溶液。采用稀释剂作为空白样品。Further, the above-mentioned preparation of the sample to be tested includes: taking 1 bottle of adenosylmethionine dimethylsulfonate special solvent for injection (specification 5ml: 428mg), pipetting 0.4ml and diluting it to 10ml with a diluent, and mixing to obtain a sample stock solution. Pipette 0.6ml of sample stock solution, add diluent to dilute to 10ml, and mix to obtain sample solution. Use the diluent as a blank sample.
进一步地,上述灵敏度溶液中DL-氨基己内酰胺的浓度为0.124μg/ml、亮氨酸的浓度为0.121μg/ml、苯丙氨酸的浓度为0.120μg/ml、苏氨酸的浓度为0.117μg/ml。Further, the concentration of DL-aminocaprolactam in the above sensitivity solution is 0.124 μg/ml, the concentration of leucine is 0.121 μg/ml, the concentration of phenylalanine is 0.120 μg/ml, and the concentration of threonine is 0.117 μg /ml.
如本申请背景技术所分析的,现有技术通常是对注射用丁二磺酸腺苷蛋氨酸专用溶剂中的一种氨基酸杂质进行限度检测,而不能对其他氨基酸类杂质进行定量检测,进而导致不能对其他氨基酸类杂质的有效质量控制。As analyzed in the background technology of this application, the prior art usually conducts a limit detection of one amino acid impurity in the special solvent for adenosylmethionine succinate for injection, but cannot quantitatively detect other amino acid impurities, which leads to inability to Effective quality control of other amino acid impurities.
如本申请背景技术所分析的,现有技术没有能够通过一种方法即可高效检测注射用丁二磺酸腺苷蛋氨酸专用溶剂中的氨基酸类杂质的技术,本申请提供了一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法,该检测方法包括:配制标准品溶液和灵敏度溶液;配制待检测样品,取注射用丁二磺酸腺苷蛋氨酸专用溶剂用稀释剂稀释溶解形成溶液;将所述待检测样品采用高效液相色谱-质谱联用仪进行检测,获取氨基酸类杂质的高效液相色谱串联质谱的标准品和样品的质量色谱图,根据质量色谱图的分析结果确定质量色谱图中各种氨基酸类杂质的特征离子峰,并将样品中特征离子峰的峰面积以标准品特征离子峰的峰面积为依据计算得出各氨基酸类杂质的质量含量。As analyzed in the background technology of this application, there is no technology in the prior art that can efficiently detect amino acid impurities in the special solvent for adenosylmethionine succinate for injection by a single method. The detection method of amino acid impurities in the special solvent for adenosylmethionine disulfonate, the detection method includes: preparing a standard solution and a sensitivity solution; preparing a sample to be tested, taking the special solvent for adenosylmethionine butanedisulfonate for injection and diluting it with a diluent Dissolving to form a solution; the sample to be detected is detected by high performance liquid chromatography-mass spectrometry, and the mass chromatogram of the standard product of high performance liquid chromatography tandem mass spectrometry of amino acid impurities and the sample is obtained, according to the analysis of the mass chromatogram Results Determine the characteristic ion peaks of various amino acid impurities in the mass chromatogram, and calculate the mass content of each amino acid impurity based on the peak area of the characteristic ion peaks in the sample.
本申请通过高效液相色谱和质谱进行串联对注射用丁二磺酸腺苷蛋氨酸专用溶剂进行测试时,高效液相色谱对注射用丁二磺酸腺苷蛋氨酸专用溶剂中的各杂质进行分离,然后质谱对分离物进行进一步的检测得到相应质量色谱图,利用质量色谱图可以确定氨基酸类杂质以及对应的色谱图中氨基酸类杂质的特征离子峰,依据该特征离子峰面积和标准品峰面积即可得到氨基酸类杂质的质量含量。由此可见,本申请在实现了利用高效液相色谱对氨基酸类杂质充分分离的基础上,利用质谱数据精确对应质量色谱图中氨基酸类杂质的特征离子峰,从而得到氨基酸类杂质的精确质量含量,为对氨基酸类杂质的有效质量控制提供可靠数据基础。In this application, when the high-performance liquid chromatography and mass spectrometry are used to test the special solvent for adenosylmethionine succinate for injection, the high performance liquid chromatography is used to separate the impurities in the special solvent for adenosylmethionine succinate for injection. Then mass spectrometry carries out further detection to isolate and obtains corresponding mass chromatogram, utilizes mass chromatogram to determine the characteristic ion peak of amino acid impurity and amino acid impurity in corresponding chromatogram, according to this characteristic ion peak area and standard product peak area namely The mass content of amino acid impurities can be obtained. It can be seen that, on the basis of realizing the sufficient separation of amino acid impurities by high performance liquid chromatography, the application uses mass spectrometry data to accurately correspond to the characteristic ion peaks of amino acid impurities in the mass chromatogram, thereby obtaining the accurate mass content of amino acid impurities , to provide a reliable data basis for the effective quality control of amino acid impurities.
本申请中标准曲线的建立可以参考现有技术中液相色谱测试常用的标准曲线建立的流程,在一种实施例中,上述步骤S1采用氨基酸类杂质标准品的溶液作为标准溶液,优选配制标准溶液的溶剂为稀释剂,优选稀释剂为甲醇和水的混合物,更优选甲醇和水的体积比为60:40。The establishment of the standard curve in this application can refer to the process of establishing the standard curve commonly used in the liquid chromatography test in the prior art. In one embodiment, the above step S1 uses the solution of the amino acid impurity standard as the standard solution, preferably preparing the standard The solvent of the solution is a diluent, preferably the diluent is a mixture of methanol and water, more preferably the volume ratio of methanol and water is 60:40.
由于氨基酸类杂质作为杂质存在于注射用丁二磺酸腺苷蛋氨酸专用溶剂中,其含量较微,为了更进一步地保证测试结果的准确性,优选上述标准溶液中氨基酸类杂质的质量含量为0.4μg/mL。采用上述浓度的标准溶液为测试基础绘制得到的标准曲线的可靠性更好。Since amino acid impurities exist as impurities in the special solvent for adenosylmethionine succinate for injection, their content is relatively small. In order to further ensure the accuracy of the test results, the mass content of amino acid impurities in the above-mentioned standard solution is preferably 0.4 μg/mL. The reliability of the standard curve obtained by using the standard solution of the above concentration as the basis of the test is better.
为了使注射用丁二磺酸腺苷蛋氨酸专用溶剂中的氨基酸类杂质尽可能在短时间内完全溶出,优选上述步骤S2中采用稀释剂稀释注射用丁二磺酸腺苷蛋氨酸专用溶剂形成样品溶液,优选稀释剂为甲醇和水的混合物,更优选甲醇和水的体积比为60:40。In order to completely dissolve the amino acid impurities in the special solvent for adenosylmethionine for injection as soon as possible, it is preferable to dilute the special solvent for adenosylmethionine for injection with a diluent in the above step S2 to form a sample solution , the preferred diluent is a mixture of methanol and water, more preferably the volume ratio of methanol and water is 60:40.
在对注射用丁二磺酸腺苷蛋氨酸专用溶剂进行高效液相色谱检测时,本申请对检测条件进行了深入研究,尤其是在使用不同色谱柱的前提下,对流动相的组成和梯度洗脱程序的配合进行了试验研究,最终确定高效液相色谱检测的条件设定包括:色谱柱为Poroshell 120 HILIC-Z色谱柱,柱温为30~40℃,流速为0.8ml/min;流动相A为乙腈和缓冲溶液按照体积比95:5的混合溶液、流动相B为乙腈和缓冲溶液按照体积比50:50的混合溶液,所述缓冲溶液均为10mM甲酸铵水溶液用甲酸调节pH至3.0的溶液;流动相的洗脱方式为梯度洗脱,所述梯度洗脱程序为:When performing high-performance liquid chromatography detection on the special solvent for adenosylmethionine succinate for injection, this application has carried out in-depth research on the detection conditions, especially on the premise of using different chromatographic columns, the composition of the mobile phase and the gradient wash method. The experimental research was carried out with the cooperation of off-programming, and the conditions for the detection of high-performance liquid chromatography were finally determined to include: the chromatographic column was a Poroshell 120 HILIC-Z chromatographic column, the column temperature was 30-40°C, and the flow rate was 0.8ml/min; the mobile phase A is a mixed solution of acetonitrile and buffer solution according to the volume ratio of 95:5, and mobile phase B is a mixed solution of acetonitrile and buffer solution according to the volume ratio of 50:50. The solution; The elution mode of mobile phase is gradient elution, and described gradient elution procedure is:
时间(min)time (min) 流动相A(%)Mobile phase A(%) 流动相B(%)Mobile phase B(%)
0.00.0 7575 2525
13.013.0 5050 5050
13.513.5 1010 9090
18.018.0 1010 9090
18.118.1 7575 2525
25.025.0 7575 2525
优选地,所述柱温为30℃。Preferably, the column temperature is 30°C.
优选地,进样体积为2ul。Preferably, the injection volume is 2ul.
在上述条件下,尤其是采用Poroshell 120 HILIC-Z色谱柱与上述流动相A和流动相B的组合,实现了对氨基酸类杂质与其它杂质的有效分离,进而实现了对氨基酸类杂质的质量测定。同时,上述流动相A和流动相B的性质稳定,进一步使得检测结果更加可靠。Under the above conditions, especially the combination of Poroshell 120 HILIC-Z chromatographic column and the above mobile phase A and mobile phase B, the effective separation of amino acid impurities and other impurities is realized, and the mass determination of amino acid impurities is realized. . At the same time, the properties of the above-mentioned mobile phase A and mobile phase B are stable, which further makes the detection result more reliable.
为了提高质谱检测结果的准确性,优选上述质谱检测的条件设定包括:离子源为电喷雾离子源(AJS ESI),质谱检测器为三重四级杆检测器(QQQ),干燥气温度为300~350℃,干燥气流速为9~11L/min,雾化气压力为50~55psi,鞘流气温度为360~390℃,鞘流气流速为10~12L/min,毛细管端电压为3000~4000V,喷嘴电压为450~550V,扫描模式为质谱多反应检测(MRM)。In order to improve the accuracy of the mass spectrometry detection results, the condition setting of the above-mentioned mass spectrometry detection preferably includes: the ion source is an electrospray ionization source (AJS ESI), the mass spectrometry detector is a triple quadrupole detector (QQQ), and the drying gas temperature is 300 ~350°C, drying gas flow rate is 9~11L/min, atomizing gas pressure is 50~55psi, sheath flow gas temperature is 360~390°C, sheath flow flow rate is 10~12L/min, capillary terminal voltage is 3000~4000V, The nozzle voltage was 450-550V, and the scanning mode was mass spectrometry multiple reaction monitoring (MRM).
在一种优选的实施例中,上述质谱检测的条件设定包括:离子源为电喷雾离子源(AJS ESI),质谱检测器为三重四级杆检测器(QQQ),干燥气温度为350℃,干燥气流速为11L/min,雾化气压力为55psi,鞘流气温度为390℃,鞘流气流速为12L/min,毛细管端电压为+3500V,喷嘴电压为+500V,扫描模式为质谱多反应检测(MRM),参数为:In a preferred embodiment, the condition settings for the above-mentioned mass spectrometry detection include: the ion source is an electrospray ion source (AJS ESI), the mass spectrometer detector is a triple quadrupole detector (QQQ), and the drying gas temperature is 350°C , the drying gas flow rate is 11L/min, the atomizing gas pressure is 55psi, the sheath gas temperature is 390°C, the sheath gas flow rate is 12L/min, the capillary terminal voltage is +3500V, the nozzle voltage is +500V, and the scanning mode is mass spectrometry multiple reaction Detection (MRM), the parameters are:
Figure PCTCN2021143530-appb-000002
Figure PCTCN2021143530-appb-000002
本发明与现有的注射用丁二磺酸腺苷蛋氨酸专用溶剂中检测杂质的方法相比,改变了薄层色谱检测的繁琐的检测步骤,避免使用有机有毒的展开剂和显色剂,对研究者而言是一种更加有益健康的方法,同时还能对多个氨基酸类杂质的量进行有效质量控制。解决了现有技术中的注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质不能有效定量的问题,并且通过一种方法即可检测注射用丁二磺酸腺苷蛋氨酸专用溶剂中各氨基酸类杂质含量。Compared with the existing method for detecting impurities in the special solvent for adenosylmethionine succinate for injection, the present invention changes the cumbersome detection steps of thin-layer chromatography detection, avoids the use of organic and toxic developing agents and chromogenic agents, and is beneficial to For researchers, it is a more healthy method, and at the same time, it can effectively control the amount of multiple amino acid impurities. It solves the problem that amino acid impurities in the special solvent for adenosylmethionine succinate for injection in the prior art cannot be effectively quantified, and can detect each amino acid in the special solvent for adenosylmethionine succinate for injection by one method content of impurities.
本发明所述的注射用丁二磺酸腺苷蛋氨酸专用溶剂为L-赖氨酸的灭菌溶液,每支(5ml)中含L-赖氨酸(C 6H 14N 2O 2)应为385~450mg,L-赖氨酸的化学结构如下: The special solvent for adenosylmethionine succinate for injection of the present invention is a sterilized solution of L-lysine, and each (5ml) containing L-lysine (C 6 H 14 N 2 O 2 ) should be The chemical structure of L-lysine is as follows:
Figure PCTCN2021143530-appb-000003
Figure PCTCN2021143530-appb-000003
附图说明Description of drawings
图1为标准品溶液中氨基酸类杂质的总离子色谱图;Fig. 1 is the total ion chromatogram of amino acid impurities in the standard solution;
图2为标准品溶液中DL-氨基己内酰胺的多反应监测提取离子色谱图;Fig. 2 is the multiple reaction monitoring extracted ion chromatogram of DL-aminocaprolactam in the standard solution;
图3为标准品溶液中亮氨酸的多反应监测提取离子色谱图;Fig. 3 is the MRM extraction ion chromatogram of leucine in standard solution;
图4为标准品溶液中苯丙氨酸的多反应监测提取离子色谱图;Fig. 4 is the MRM extraction ion chromatogram of phenylalanine in the standard solution;
图5为标准品溶液中苏氨酸的多反应监测提取离子色谱图;Fig. 5 is the MRM extraction ion chromatogram of threonine in the standard solution;
图6为样品溶液中氨基酸类杂质的总离子色谱图;Fig. 6 is the total ion chromatogram of amino acid impurities in the sample solution;
图7为样品溶液中DL-氨基己内酰胺的多反应监测提取离子色谱图;Fig. 7 is the MRM extraction ion chromatogram of DL-aminocaprolactam in the sample solution;
图8为样品溶液中亮氨酸的多反应监测提取离子色谱图;Figure 8 is an MRM-extracted ion chromatogram of leucine in the sample solution;
图9为样品溶液中苯丙氨酸的多反应监测提取离子色谱图;Fig. 9 is the multiple reaction monitoring extracted ion chromatogram of phenylalanine in the sample solution;
图10为样品溶液中苏氨酸的多反应监测提取离子色谱图;Figure 10 is the multiple reaction monitoring extracted ion chromatogram of threonine in the sample solution;
图11为DL-氨基己内酰胺标准曲线;Fig. 11 is DL-amino caprolactam standard curve;
图12为亮氨酸标准曲线;Figure 12 is a leucine standard curve;
图13为苯丙氨酸标准曲线;Fig. 13 is phenylalanine standard curve;
图14为苏氨酸标准曲线。Figure 14 is a threonine standard curve.
具体实施方式Detailed ways
需要说明的是,在不冲突的情况下,本申请中的实施例及实施例中的特征可以相互组合。下述实施例来详细说明本发明。It should be noted that, in the case of no conflict, the embodiments in the present application and the features in the embodiments can be combined with each other. The following examples illustrate the invention in detail.
以下检测所采用的仪器和试剂如下。The instruments and reagents used in the following tests are as follows.
仪器instrument
Agilent HPLC1260-MS QQQ 6460Agilent HPLC1260-MS QQQ 6460
试剂Reagent
甲醇,色谱级;Methanol, chromatography grade;
甲酸,质谱级;Formic acid, mass spec grade;
乙腈,色谱级;Acetonitrile, chromatography grade;
甲酸铵,色谱级;Ammonium formate, chromatography grade;
纯化水。purified water.
注射用丁二磺酸腺苷蛋氨酸专用溶剂由由浙江海正药业股份有限公司提供The special solvent for adenosylmethionine butyl disulfonate for injection is provided by Zhejiang Hisun Pharmaceutical Co., Ltd.
实施例1Example 1
以下检测中涉及的高效液相色谱-质谱联用仪的检测条件为:The detection conditions of the high-performance liquid chromatography-mass spectrometer involved in the following detection are:
高效液相色谱检测的条件设定如下:色谱柱为Poroshell 120 HILIC-Z色谱柱,进样体积为2ul,柱温为30℃,流速为0.8ml/min,流动相A为乙腈和缓冲溶液按照体积比95:5的混合溶液、流动相B为乙腈和缓冲溶液按照体积比50:50的混合溶液,所述缓冲溶液均为10mM甲酸铵水溶液用甲酸调节pH至3.0的溶液;The conditions for high-performance liquid chromatography detection are set as follows: the chromatographic column is a Poroshell 120 HILIC-Z chromatographic column, the injection volume is 2ul, the column temperature is 30°C, the flow rate is 0.8ml/min, and the mobile phase A is acetonitrile and buffer solution according to The mixed solution of volume ratio 95:5, mobile phase B is the mixed solution of acetonitrile and buffer solution according to volume ratio 50:50, and described buffer solution is the solution that 10mM ammonium formate aqueous solution adjusts pH to 3.0 with formic acid;
流动相的洗脱方式为梯度洗脱,所述梯度洗脱程序为:The elution mode of mobile phase is gradient elution, and described gradient elution procedure is:
时间(min)time (min) A(%)A(%) B(%)B(%)
0.00.0 7575 2525
13.013.0 5050 5050
13.513.5 1010 9090
18.018.0 1010 9090
18.118.1 7575 2525
25.025.0 7575 2525
质谱检测的条件设定如下:离子源为电喷雾离子源(AJS ESI),质谱检测器为三重四级杆检测器(QQQ),干燥气温度为350℃,干燥气流速为11L/min,雾化气压力为55psi,鞘流气温度为390℃,鞘流气流速为12L/min,毛细管端电压为+3500V,喷嘴电压为+500V,扫描模式为MRM,参数为:The conditions for mass spectrometry detection were set as follows: the ion source was an electrospray ionization source (AJS ESI), the mass spectrometer detector was a triple quadrupole detector (QQQ), the drying gas temperature was 350 °C, the drying gas flow rate was 11 L/min, and the fog The gas pressure is 55psi, the sheath gas temperature is 390°C, the sheath gas flow rate is 12L/min, the capillary end voltage is +3500V, the nozzle voltage is +500V, the scan mode is MRM, and the parameters are:
Figure PCTCN2021143530-appb-000004
Figure PCTCN2021143530-appb-000004
系统适用性的建立过程System Suitability Establishment Process
标准溶液配制过程如下:The standard solution preparation process is as follows:
标准溶液即系统适应性溶液:采用稀释剂将苯丙氨酸、亮氨酸、苏氨酸各5mg,DL-氨基己内酰胺盐酸盐6.4mg(相当于DL-氨基己内酰胺5mg),加稀释剂配置成浓度均为0.4μg/ml的混合标准溶液。The standard solution is the system suitability solution: use a diluent to prepare 5 mg each of phenylalanine, leucine, and threonine, and 6.4 mg of DL-aminocaprolactam hydrochloride (equivalent to 5 mg of DL-aminocaprolactam). A mixed standard solution with a concentration of 0.4 μg/ml was prepared.
灵敏度溶液配制过程如下:The sensitivity solution preparation process is as follows:
精密移取3.0ml标准溶液,加稀释剂稀释至10ml,混匀可得。Precisely pipette 3.0ml standard solution, add diluent to dilute to 10ml, and mix well.
样品溶液配制过程如下:The sample solution preparation process is as follows:
取1瓶注射用丁二磺酸腺苷蛋氨酸专用溶剂(规格5ml:428mg),移取0.4ml用稀释剂稀释至10ml,混匀得样品储备液。移取样品储备液0.6ml,加稀释剂稀释至10ml,混匀得样品溶液。Take 1 bottle of special solvent for ademethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with a diluent, and mix well to obtain a sample stock solution. Pipette 0.6ml of sample stock solution, add diluent to dilute to 10ml, and mix to obtain sample solution.
样品溶液的检测条件同标准溶液的检测条件。The detection conditions of the sample solution are the same as those of the standard solution.
对标准溶液进行高效液相色谱串联质谱的检测过程设定如下:The detection process of carrying out high performance liquid chromatography tandem mass spectrometry to standard solution is set as follows:
进流动相和稀释剂,检查基线和漂移,直到系统稳定为止。进一针灵敏度溶液,各标准品峰的信噪比应不小于10。再连续进6针标准品溶液,各标准品峰面积的RSD均应不大于10%。各杂质的保留时间如下:Add mobile phase and diluent, check for baseline and drift, until the system is stable. Inject a needle of sensitivity solution, the signal-to-noise ratio of each standard peak should not be less than 10. Then inject 6 needles of standard solution continuously, and the RSD of the peak area of each standard should be no more than 10%. The retention time of each impurity is as follows:
标准品Standard DL-氨基己内酰胺DL-Aminocaprolactam 亮氨酸Leucine 苯丙氨酸Phenylalanine 苏氨酸threonine
保留时间(min)retention time (min) 6.882±16.882±1 5.684±15.684±1 5.368±15.368±1 9.887±19.887±1
为了评价整个序列运行过程中系统是否稳定,每进不多于8针样品溶液和序列完成后,进一针标准品溶液作为中控标准溶液。计算中控标准溶液与初始6针连续进样标准品溶液中各标准品峰面积的RSD,RSD应不大于10%。(注:必要时可适当进一针稀释剂,清洗管路残留)。In order to evaluate whether the system is stable during the entire sequence operation, inject no more than 8 needles of sample solution and after the sequence is completed, inject a needle of standard solution as the central control standard solution. Calculate the RSD of the peak area of each standard in the central control standard solution and the initial 6-shot continuous injection standard solution, and the RSD should not be greater than 10%. (Note: If necessary, a shot of diluent can be properly injected to clean the pipeline residue).
样品溶液氨基酸类杂质的计算过程如下:The calculation process of amino acid impurities in the sample solution is as follows:
按照下面杂质计算公式计算样品中苯丙氨酸、亮氨酸、DL-氨基己内酰胺、苏氨酸的含量:Calculate the content of phenylalanine, leucine, DL-aminocaprolactam, and threonine in the sample according to the impurity calculation formula below:
Figure PCTCN2021143530-appb-000005
Figure PCTCN2021143530-appb-000005
其中:in:
A Spl=样品溶液中各氨基酸的峰面积; A Spl = the peak area of each amino acid in the sample solution;
A Std=6针标准品溶液中各标准品的平均峰面积; A Std = the average peak area of each standard product in 6 needle standard product solutions;
W Std=标准品溶液中各标准品的称样量,用mg表示; W Std = the weighing amount of each standard in the standard solution, expressed in mg;
V Std=标准品溶液中各标准品的稀释体积,用ml表示; V Std = the dilution volume of each standard in the standard solution, expressed in ml;
D=样品稀释倍数;D = sample dilution factor;
P=各标准品的纯度;P = the purity of each standard;
Lc=注射用丁二磺酸腺苷蛋氨酸专用溶剂标示量,为428mg/5ml=85.6mg/ml。Lc = labeled amount of adenosylmethionine dimethylsulfonate special solvent for injection, which is 428mg/5ml = 85.6mg/ml.
准确度回收率与精密度验证采用添加法进行检测。Accuracy recovery and precision verification were detected by addition method.
准确度储备液:称取苯丙氨酸4.822mg、亮氨酸5.040mg、苏氨酸4.898mg,DL-氨基己内酰胺盐酸盐6.669mg同置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀得储备液A。精密移取0.4ml储备液A于10ml容量瓶中,用稀释剂稀释至刻度,混匀得准确度储备液。Accuracy stock solution: Weigh 4.822mg of phenylalanine, 5.040mg of leucine, 4.898mg of threonine, and 6.669mg of DL-aminocaprolactam hydrochloride in a 25ml volumetric flask, dissolve with diluent and Dilute to the mark and mix to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain the accuracy stock solution.
样品储备液:取1瓶注射用丁二磺酸腺苷蛋氨酸专用溶剂(规格5ml:428mg),移取0.4ml用稀释剂稀释至10ml,混匀得样品储备液Sample stock solution: Take 1 bottle of special solvent for adenosylmethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with diluent, and mix well to obtain the sample stock solution
30%准确度样品溶液:取0.15ml准确度储备液和0.6ml样品储备液,用稀释剂稀释至10ml,混匀,即得。平行配制3份30% accuracy sample solution: take 0.15ml accuracy stock solution and 0.6ml sample stock solution, dilute to 10ml with diluent, mix well, and get ready. Prepare 3 copies in parallel
100%准确度样品溶液:取0.5ml准确度储备液和0.6ml样品储备液,用稀释剂稀释至10ml,混匀,即得。平行配制3份。100% accuracy sample solution: take 0.5ml accuracy stock solution and 0.6ml sample stock solution, dilute to 10ml with diluent, mix well, and get ready. Prepare 3 copies in parallel.
200%准确度样品溶液:取1.0ml准确度储备液和0.6ml样品储备液,用稀释剂稀释至10ml,混匀,即得。平行配制3份。200% accuracy sample solution: take 1.0ml accuracy stock solution and 0.6ml sample stock solution, dilute to 10ml with diluent, mix well, and get ready. Prepare 3 copies in parallel.
认可标准:每个浓度三份样品的平均回收率在70%~130%。(参考中国药典分析方法验证规程)Acceptance standard: the average recovery rate of three samples of each concentration is 70%-130%. (Refer to the Chinese Pharmacopoeia Analytical Method Validation Regulations)
进流动和稀释剂,检查基线和漂移,直到系统稳定为止。进一针灵敏度溶液,各标准品峰的信噪比应不小于10。再连续进6针标准品溶液,各标准品峰面积的RSD均应不大于10%,每份样品溶液进1针,进不多于8针样品溶液和序列结束时分别进一针中控标准溶液(标准品溶液)。根据标准品溶液的浓度和质量色谱图计算各非挥发性浸出物的检出量、回收率及每个浓度的平均回收率。Inject flow and diluent, check for baseline and drift, until the system is stable. Inject a needle of sensitivity solution, the signal-to-noise ratio of each standard peak should not be less than 10. Then inject 6 needles of standard solution continuously, the RSD of the peak area of each standard should be no more than 10%, inject 1 needle for each sample solution, and inject no more than 8 needles of sample solution and one needle of central control standard at the end of the sequence solution (standard solution). According to the concentration and mass chromatogram of the standard solution, the detected amount, recovery rate and average recovery rate of each concentration of non-volatile extracts were calculated.
计算结果见下表1-表4。The calculation results are shown in Table 1-Table 4 below.
表1.DL-氨基己内酰胺准确度实验结果Table 1. DL-aminocaprolactam accuracy test results
Figure PCTCN2021143530-appb-000006
Figure PCTCN2021143530-appb-000006
表2.亮氨酸准确度实验结果Table 2. Experimental results of leucine accuracy
Figure PCTCN2021143530-appb-000007
Figure PCTCN2021143530-appb-000007
表3.苯丙氨酸准确度实验结果Table 3. Experimental results of phenylalanine accuracy
Figure PCTCN2021143530-appb-000008
Figure PCTCN2021143530-appb-000008
表4.苏氨酸准确度实验结果Table 4. Experimental results of threonine accuracy
Figure PCTCN2021143530-appb-000009
Figure PCTCN2021143530-appb-000009
线性验证linearity verification
标准品溶液的配制Preparation of standard solution
称取苯丙氨酸5.001mg、亮氨酸5.033mg、苏氨酸4.883mg,DL-氨基己内酰胺盐酸盐6.662mg同置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀得标准品储备液A。精密移取0.4ml储备液A于10ml容量瓶中,用稀释剂稀释至刻度,混匀得标准品储备液B。精密移取0.5ml储备液B于10ml容量瓶中,用稀释剂稀释至刻度,混匀得苯丙氨酸、亮氨酸、苏氨酸、DL-氨基己内酰胺浓度均约为0.4μg/ml的标准品溶液。Weigh 5.001mg of phenylalanine, 5.033mg of leucine, 4.883mg of threonine, 6.662mg of DL-aminocaprolactam hydrochloride and place them in a 25ml volumetric flask, dissolve them with a diluent and adjust the volume to the mark. Mix well to obtain standard stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain standard stock solution B. Precisely pipette 0.5ml of stock solution B into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a concentration of phenylalanine, leucine, threonine, and DL-aminocaprolactam of about 0.4μg/ml Standard solution.
线性储备液的配制Preparation of linear stock solutions
线性储备液与上述标准品储备液B为同一份。The linear stock solution is the same as the standard stock solution B above.
线性溶液的配制Preparation of linear solutions
用线性储备液配制线性溶液,详见表5。Prepare a linear solution using the linear stock solution, see Table 5 for details.
表5.线性溶液的配制Table 5. Preparation of linear solutions
Figure PCTCN2021143530-appb-000010
Figure PCTCN2021143530-appb-000010
认可标准Accreditation standard
相关系数(R 2)不小于0.98 The correlation coefficient (R 2 ) is not less than 0.98
DL-氨基己内酰胺、亮氨酸、苯丙氨酸和苏氨酸的线性结果见表6-表9,图11-图14。The linearity results of DL-aminocaprolactam, leucine, phenylalanine and threonine are shown in Table 6-Table 9, Figure 11-Figure 14.
表6.DL-氨基己内酰胺线性实验结果Table 6. DL-aminocaprolactam linearity test results
Figure PCTCN2021143530-appb-000011
Figure PCTCN2021143530-appb-000011
表7.亮氨酸线性实验结果Table 7. Leucine linearity test results
Figure PCTCN2021143530-appb-000012
Figure PCTCN2021143530-appb-000012
表8.苯丙氨酸线性实验结果Table 8. Results of phenylalanine linearity experiment
Figure PCTCN2021143530-appb-000013
Figure PCTCN2021143530-appb-000013
表9.苏氨酸线性实验结果Table 9. Threonine linearity experiment results
Figure PCTCN2021143530-appb-000014
Figure PCTCN2021143530-appb-000014
专属性验证Exclusive verification
标准品溶液的配制Preparation of standard solution
称取苯丙氨酸5.001mg、亮氨酸5.033mg、苏氨酸4.883mg,DL-氨基己内酰胺盐酸盐6.662mg同置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀得标准品储备液A。精密移取0.4ml储备液A于10ml容量瓶中,用稀释剂稀释至刻度,混匀标准品得储备液B。精密移取0.5ml储备液B于10ml容量瓶中,用稀释剂稀释至刻度,混匀得苯丙氨酸、亮氨酸、苏氨酸、DL-氨基己内酰胺浓度均约为0.4μg/ml的标准品溶液。Weigh 5.001mg of phenylalanine, 5.033mg of leucine, 4.883mg of threonine, 6.662mg of DL-aminocaprolactam hydrochloride and place them in a 25ml volumetric flask, dissolve them with a diluent and adjust the volume to the mark. Mix well to obtain standard stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix the standard to obtain stock solution B. Precisely pipette 0.5ml of stock solution B into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a concentration of phenylalanine, leucine, threonine, and DL-aminocaprolactam of about 0.4μg/ml Standard solution.
苯丙氨酸标准品溶液的配制Preparation of phenylalanine standard solution
称取苯丙氨酸4.938mg置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀。精密移取上述溶液20μl于10ml容量瓶中,用稀释剂稀释至刻度,混匀得浓度约为0.4μg/ml的苯丙氨酸标准品溶液。Weigh 4.938mg of phenylalanine and place it in a 25ml volumetric flask, dissolve it with a diluent and set the volume to the mark, and mix well. Precisely pipette 20 μl of the above solution into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a phenylalanine standard solution with a concentration of about 0.4 μg/ml.
亮氨酸标准品溶液的配制Preparation of leucine standard solution
称取亮氨酸4.900mg置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀。精密移取上述溶液20μl于10ml容量瓶中,用稀释剂稀释至刻度,混匀得浓度约为0.4μg/ml的亮氨酸标准品溶液。Weigh 4.900mg of leucine and place it in a 25ml volumetric flask, dissolve it with a diluent and set the volume to the mark, and mix well. Precisely pipette 20 μl of the above solution into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a leucine standard solution with a concentration of about 0.4 μg/ml.
DL-氨基己内酰胺标准溶液的配制Preparation of DL-aminocaprolactam standard solution
称取DL-氨基己内酰胺盐酸盐6.477mg置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀。精密移取上述溶液20μl于10ml容量瓶中,用稀释剂稀释至刻度,混匀得浓度约为0.4μg/ml的DL-氨基己内酰胺标准品溶液。Weigh 6.477mg of DL-aminocaprolactam hydrochloride and place it in a 25ml volumetric flask, dissolve it with diluent and set the volume to the mark, and mix well. Precisely pipette 20 μl of the above solution into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a DL-aminocaprolactam standard solution with a concentration of about 0.4 μg/ml.
苏氨酸标准品溶液的配制Preparation of threonine standard solution
称取苏氨酸4.868mg置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀。精密移取上述溶液20μl于10ml容量瓶中,用稀释剂稀释至刻度,混匀得浓度约为0.4μg/ml的苏氨酸标准品溶液。Weigh 4.868mg of threonine and place it in a 25ml volumetric flask, dissolve it with a diluent and set the volume to the mark, and mix well. Precisely pipette 20 μl of the above solution into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a threonine standard solution with a concentration of about 0.4 μg/ml.
样品储备液的配制Preparation of sample stock solutions
取1瓶注射用丁二磺酸腺苷蛋氨酸专用溶剂(规格5ml:428mg),移取0.4ml用稀释剂稀释至10ml,混匀得样品储备液。Take 1 bottle of special solvent for ademethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with a diluent, and mix well to obtain a sample stock solution.
空白样品溶液的配制Preparation of blank sample solution
移取上述样品储备液0.6ml,加稀释剂稀释至10ml,混匀,即得。Pipette 0.6ml of the above sample stock solution, add diluent to dilute to 10ml, mix well, and obtain.
加标样品溶液的配制Preparation of spiked sample solution
取0.5ml上述标准品储备液B和0.6ml样品储备液,用稀释剂稀释至10ml,混匀,即得。Take 0.5ml of the above standard stock solution B and 0.6ml of the sample stock solution, dilute to 10ml with diluent, mix well, and obtain.
认可标准Accreditation standard
空白溶剂(流动相、稀释剂)在各氨基酸的保留时间窗内的干扰均不得大于各标准品溶液的10%。(必要时采取一定措施)The interference of the blank solvent (mobile phase, diluent) in the retention time window of each amino acid shall not be greater than 10% of each standard solution. (Take certain measures when necessary)
专属性结果详见表10。The specificity results are detailed in Table 10.
表10.专属性实验结果Table 10. Specificity experiment results
Figure PCTCN2021143530-appb-000015
Figure PCTCN2021143530-appb-000015
检出限和定量限验证Limit of detection and limit of quantitation verification
(LOQ)定量限溶液:(LOQ) limit of quantitation solution:
标准品溶液:称取苯丙氨酸5.001mg、亮氨酸5.033mg、苏氨酸4.883mg,DL-氨基己内酰胺盐酸盐6.662mg同置于一个25ml的容量瓶中,用稀释剂溶解并定容至刻度,混匀得储备液A。精密移取0.4ml储备液A于10ml容量瓶中,用稀释剂稀释至刻度,混匀得储备液B。精密移取0.5ml储备液B于10ml容量瓶中,用稀释剂稀释至刻度,混匀得苯丙氨酸、亮氨酸、苏氨酸、DL-氨基己内酰胺浓度均约为0.4μg/ml的标准品溶液Standard solution: Weigh 5.001mg of phenylalanine, 5.033mg of leucine, 4.883mg of threonine, and 6.662mg of DL-aminocaprolactam hydrochloride in a 25ml volumetric flask, dissolve and set Make up to the mark and mix well to obtain stock solution A. Precisely pipette 0.4ml of stock solution A into a 10ml volumetric flask, dilute to the mark with diluent, and mix well to obtain stock solution B. Precisely pipette 0.5ml of stock solution B into a 10ml volumetric flask, dilute to the mark with a diluent, and mix well to obtain a concentration of phenylalanine, leucine, threonine, and DL-aminocaprolactam of about 0.4μg/ml Standard solution
移取上述标准品溶液3.0ml,加入稀释剂稀释至10ml,混匀,作为定量限溶液。Pipette 3.0ml of the above standard solution, add diluent to dilute to 10ml, mix well, and use it as the limit of quantitation solution.
(LOD)检测限溶液:移取上述标准品溶液1.5ml,加入稀释剂稀释至10ml,混匀,作为检测限溶液。(LOD) limit of detection solution: pipette 1.5ml of the above standard solution, add diluent to dilute to 10ml, mix well, and use it as the limit of detection solution.
认可标准:Accreditation standard:
6针LOQ溶液中各氨基酸类杂质的信噪比均≥10;The signal-to-noise ratio of each amino acid impurity in the 6-pin LOQ solution is ≥10;
6针LOQ溶液中氨基酸类杂质峰面积的RSD均≤15%;The RSDs of the peak areas of amino acid impurities in the 6-pin LOQ solutions were all ≤15%;
3针LOD溶液中氨基酸类杂质的信噪比均≥3。The signal-to-noise ratios of amino acid impurities in the 3-shot LOD solutions were all ≥3.
溶液的质量色谱图的特征离子峰面积和信噪比结果见表11-表12。The characteristic ion peak area and signal-to-noise ratio results of the mass chromatogram of the solution are shown in Table 11-Table 12.
表11.LOQ实验结果Table 11. LOQ experimental results
Figure PCTCN2021143530-appb-000016
Figure PCTCN2021143530-appb-000016
表12.LOD实验结果Table 12. LOD experiment results
Figure PCTCN2021143530-appb-000017
Figure PCTCN2021143530-appb-000017
注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质测定过程:Determination process of amino acid impurities in the special solvent for adenosylmethionine succinate for injection:
样品溶液:取1瓶注射用丁二磺酸腺苷蛋氨酸专用溶剂(规格5ml:428mg),移取0.4ml用稀释剂稀释至10ml,混匀得样品储备液。移取样品储备液0.6ml,加稀释剂稀释至10ml,混匀得样品溶液。稀释剂为甲醇和纯化水以60:40的体积比的混合溶剂。样品溶液平行制备两份。Sample solution: Take 1 bottle of special solvent for adenosylmethionine succinate for injection (specification 5ml: 428mg), pipette 0.4ml and dilute to 10ml with a diluent, and mix well to obtain a sample stock solution. Pipette 0.6ml of sample stock solution, add diluent to dilute to 10ml, and mix to obtain sample solution. The diluent is a mixed solvent of methanol and purified water at a volume ratio of 60:40. Sample solutions were prepared in parallel in duplicate.
色谱分析程序:待仪器色谱系统平衡后,进一针灵敏度溶液,查看信噪比,要求不小于10。再连续进6针标准品溶液,用标准品溶液的6张色谱图的峰面积计算平均值及RSD应不大于10%;每份样品溶液进1针。进不多于8针和序列结束时,分别进一针系统适应性溶液,与连续进样的前6针系统适应性溶液相比,氨基酸类杂质峰面积的RSD应不大于10%。Chromatographic analysis procedure: After the chromatographic system of the instrument is balanced, inject a needle of sensitivity solution to check the signal-to-noise ratio, which is required to be not less than 10. Inject 6 needles of standard solution continuously, and calculate the average value and RSD of the peak areas of the 6 chromatograms of standard solution should not be greater than 10%; inject 1 needle for each sample solution. Inject no more than 8 needles and at the end of the sequence, respectively inject a needle of system adaptability solution. Compared with the first 6 needles of system adaptability solution continuously injected, the RSD of the peak area of amino acid impurities should not be greater than 10%.
采用外标法并根据氨基酸各杂质的质量色谱图以及标准品溶液的浓度和质量色谱图,根据上述杂质计算公式得到各杂质的质量含量。The mass content of each impurity is obtained by using the external standard method and according to the mass chromatogram of each impurity of amino acid and the concentration and mass chromatogram of the standard solution, according to the above impurity calculation formula.
系统适应性及样品检测结果见表13-表14,典型图谱见图1-图10。See Table 13-Table 14 for system adaptability and sample test results, and see Figure 1-Figure 10 for typical spectra.
表13.系统适应性实验结果Table 13. System adaptability experiment results
Figure PCTCN2021143530-appb-000018
Figure PCTCN2021143530-appb-000018
表14.样品检测结果Table 14. Sample test results
Figure PCTCN2021143530-appb-000019
Figure PCTCN2021143530-appb-000019
Figure PCTCN2021143530-appb-000020
Figure PCTCN2021143530-appb-000020
*注:ND表示检测结果小于LOD。4种杂质的LOD均为0.03%。*Note: ND means that the detection result is less than LOD. The LODs of the four impurities are all 0.03%.
从以上的描述中,可以看出,本发明上述的实施例实现了如下技术效果:From the above description, it can be seen that the above-mentioned embodiments of the present invention have achieved the following technical effects:
本申请建立了一种高效液相色谱-质谱进行串联对注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸的方法进行测试时,采用了一种独特的色谱条件,包括流动相的组分和比列以及色谱程序,对注射用丁二磺酸腺苷蛋氨酸专用溶剂中的各氨基酸类杂质进行分离,然后质谱对对应各特征峰的分离物进行进一步的检测得到相应质量色谱图,利用质量色谱图可以确定氨基酸类杂质以及对应的色谱图中氨基酸类杂质的特征离子峰,依据该特征离子峰面积和标准品峰面积根据外标法计算即可得到氨基酸类杂质的质量含量。由此可见,本申请在实现了利用高效液相色谱对氨基酸类杂质充分分离的基础上,利用质谱数据精确对应质量色谱图中氨基酸类杂质的特征离子峰,从而得到氨基酸类杂质的精确质量含量,为对氨基酸类杂质的有效质量控制提供可靠数据基础。This application has established a high-performance liquid chromatography-mass spectrometry method for tandem testing of amino acids in the special solvent for adenosylmethionine succinate for injection. A unique chromatographic condition was adopted, including the components of the mobile phase and Separation and chromatographic procedures to separate the amino acid impurities in the special solvent for adenosylmethionine succinate for injection, and then further detect the isolates corresponding to each characteristic peak by mass spectrometry to obtain the corresponding mass chromatogram. The figure can determine the amino acid impurities and the characteristic ion peaks of the amino acid impurities in the corresponding chromatogram. According to the characteristic ion peak area and the peak area of the standard product, the mass content of the amino acid impurities can be calculated according to the external standard method. It can be seen that, on the basis of realizing the sufficient separation of amino acid impurities by high performance liquid chromatography, the application uses mass spectrometry data to accurately correspond to the characteristic ion peaks of amino acid impurities in the mass chromatogram, thereby obtaining the accurate mass content of amino acid impurities , to provide a reliable data basis for the effective quality control of amino acid impurities.
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included within the protection scope of the present invention.

Claims (6)

  1. 一种注射用丁二磺酸腺苷蛋氨酸专用溶剂中氨基酸类杂质的检测方法,其特征在于,包括:A method for detecting amino acid impurities in a special solvent for adenosylmethionine succinate for injection, characterized in that it comprises:
    步骤S1:将DL-氨基己内酰胺、苯丙氨酸、亮氨酸、苏氨酸的标准品采用稀释剂溶解得到标准品溶液;Step S1: Dissolving the standard substances of DL-aminocaprolactam, phenylalanine, leucine, and threonine in a diluent to obtain a standard solution;
    步骤S2:将注射用丁二磺酸腺苷蛋氨酸专用溶剂用稀释剂溶解得到样品溶液;Step S2: dissolving the special solvent for adenosylmethionine succinate for injection with a diluent to obtain a sample solution;
    步骤S3:采用高效液相色谱-质谱联用仪对步骤S1得到的标准品溶液和步骤S2得到的样品溶液进行检测;Step S3: using high performance liquid chromatography-mass spectrometry to detect the standard solution obtained in step S1 and the sample solution obtained in step S2;
    其中,步骤S3所述高效液相色谱的检测条件包括:Wherein, the detection condition of high performance liquid chromatography described in step S3 comprises:
    色谱柱为Poroshell 120 HILIC-Z色谱柱,柱温为30~40℃,流速为0.8ml/min;The chromatographic column is a Poroshell 120 HILIC-Z chromatographic column, the column temperature is 30-40°C, and the flow rate is 0.8ml/min;
    流动相A为乙腈和缓冲溶液按照体积比95:5的混合溶液、流动相B为乙腈和缓冲溶液按照体积比50:50的混合溶液,所述缓冲溶液均为10mM甲酸铵水溶液用甲酸调节pH至3.0的溶液;Mobile phase A is acetonitrile and buffer solution according to volume ratio 95:5 mixed solution, mobile phase B is acetonitrile and buffer solution according to volume ratio 50:50 mixed solution, and described buffer solution is 10mM ammonium formate aqueous solution and adjusts pH with formic acid to a solution of 3.0;
    流动相的洗脱方式为梯度洗脱,所述梯度洗脱程序为:The elution mode of mobile phase is gradient elution, and described gradient elution program is:
    时间(min)time (min) 流动相A(%)Mobile phase A(%) 流动相B(%)Mobile phase B(%) 0.00.0 7575 2525 13.013.0 5050 5050 13.513.5 1010 9090 18.018.0 1010 9090 18.118.1 7575 2525 25.025.0 7575 2525
    步骤S1和步骤S2所述的稀释剂均为甲醇和水按照体积比60:40的混合液体。The diluent described in step S1 and step S2 is a mixed liquid of methanol and water in a volume ratio of 60:40.
  2. 根据权利要求1所述的检测方法,其特征在于,所述柱温为30℃。The detection method according to claim 1, wherein the column temperature is 30°C.
  3. 根据权利要求2或3所述的检测方法,其特征在于,所述高效液相色谱的检测条件进一步包括:进样体积为2ul。The detection method according to claim 2 or 3, characterized in that the detection conditions of the high performance liquid chromatography further include: the injection volume is 2ul.
  4. 根据权利要求1-3任一项所述的检测方法,其特征在于,步骤S3所述质谱的检测条件包括:The detection method according to any one of claims 1-3, wherein the detection conditions of the mass spectrum in step S3 include:
    离子源为电喷雾离子源(AJS ESI),质谱检测器为三重四级杆检测器(QQQ),干燥气温度为300~350℃,干燥气流速为9~11L/min,雾化气压力为50~55psi,鞘流气温度为360~390℃,鞘流气流速为10~12L/min,毛细管端电压为3000~4000V,喷嘴电压为450~550V,扫描模式为质谱多反应检测(MRM)。The ion source is an electrospray ionization source (AJS ESI), the mass spectrometry detector is a triple quadrupole detector (QQQ), the drying gas temperature is 300-350°C, the drying gas flow rate is 9-11L/min, and the atomizing gas pressure is 50-55psi, sheath gas temperature is 360-390°C, sheath gas flow rate is 10-12L/min, capillary terminal voltage is 3000-4000V, nozzle voltage is 450-550V, and the scanning mode is mass spectrometry multiple reaction detection (MRM).
  5. 根据权利要求1-4任一项所述的检测方法,其特征在于,步骤S3所述质谱的检测条件包括:The detection method according to any one of claims 1-4, wherein the detection conditions of the mass spectrum in step S3 include:
    离子源为电喷雾离子源(AJS ESI),质谱检测器为三重四级杆检测器(QQQ),干燥气温度为350℃,干燥气流速为11L/min,雾化气压力为55psi,鞘流气温度为390℃,鞘流气流速为12L/min,毛细管端电压为+3500V,喷嘴电压为+500V,扫描模式为质谱多反应检测(MRM)。The ion source is an electrospray ion source (AJS ESI), the mass spectrometer detector is a triple quadrupole detector (QQQ), the drying gas temperature is 350°C, the drying gas flow rate is 11L/min, the nebulizing gas pressure is 55psi, and the sheath flow gas The temperature is 390°C, the sheath flow rate is 12L/min, the capillary terminal voltage is +3500V, the nozzle voltage is +500V, and the scanning mode is mass spectrometry multiple reaction monitoring (MRM).
  6. 根据权利要求5或4所述的检测方法,其特征在于,所述质谱多反应检测的参数为:The detection method according to claim 5 or 4, wherein the parameters of the mass spectrometry multiple reaction detection are:
    Figure PCTCN2021143530-appb-100001
    Figure PCTCN2021143530-appb-100001
PCT/CN2021/143530 2021-12-31 2021-12-31 Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection WO2023123309A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202180062287.9A CN117203524A (en) 2021-12-31 2021-12-31 Method for detecting amino acid impurities in solvent special for injection of butanedisulfonic acid ademetionine
PCT/CN2021/143530 WO2023123309A1 (en) 2021-12-31 2021-12-31 Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2021/143530 WO2023123309A1 (en) 2021-12-31 2021-12-31 Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection

Publications (1)

Publication Number Publication Date
WO2023123309A1 true WO2023123309A1 (en) 2023-07-06

Family

ID=86997152

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/143530 WO2023123309A1 (en) 2021-12-31 2021-12-31 Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection

Country Status (2)

Country Link
CN (1) CN117203524A (en)
WO (1) WO2023123309A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117074578A (en) * 2023-10-16 2023-11-17 瀚盟测试科技(天津)有限公司 LC-MS/MS quantitative detection method of 2- (methylamino) -ethanol

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
PENG ZHAO, WANG DONG-KAI, ZHUANG RUN, XUE MEI-YAN, WANG LI-JUN, LI LING: "Determination of Lysine and Related Compounds by RP-HPLC ", CHINESE PHARMACEUTICAL JOURNAL, vol. 41, no. 13, 8 July 2006 (2006-07-08), pages 1023 - 1026, XP093075547 *
QIANG-WEI LI, ZHI LI, WANG XIN-RONG, ZHENG-YOU HE, JIE YAO, QIANG LI, WEI LI: "HPLC-ELSD method for content determination of L-lysine in the solvent used for the ademetionine 1,4-butanedisulfonate for injection ", CHINESE JOURNAL OF ANTIBIOTICS, vol. 38, no. 12, 25 December 2013 (2013-12-25), pages 928 - 930, 946, XP093075550, DOI: 10.13461/j.cnki.cja.006078 *
QIU-JIE LIN, CHEN ZAN-MIN: "Determination of relevant compounds in Ademetionine 1,4-butanadisulfonate by HPLC ", CHINA TROPICAL MEDICINE, vol. 7, no. 8, 18 August 2007 (2007-08-18), pages 1434 - 1436, XP093075561 *
SIYU Y YANG, YIQI LI , JIEJIA GE, HONGCHUN PAN, & HONG LIU: "Compatible Stability Study of Ademetionine1, 4-Butanedisulfonate for Injection", ACTA FARMACEUTICA BONAERENSE, COLEGIO DE FARMACEUTICOS DE LA PROVINCIA DE BUENOS AIRES, AR, vol. 37, no. 11, 31 December 2018 (2018-12-31), AR , pages 2254 - 2262, XP009546852, ISSN: 0326-2383 *
WEI WU, ZHANG JINSONG, YU JIANSHENG, YAO LIDONG, XIE ZHIPENG: "Determination of Related Substances in Raw Materials and Preparations of 1,4-Butanedisulfoadenosylmethionine by HPLC", HERALD OF MEDICINE, vol. 27, no. 7, 1 July 2008 (2008-07-01), pages 846 - 847, XP093075563 *
YONG WU, LI YUHAN: "Structure Elucidation of Impurities in Ademetionine l,4-Butanedisulfonate by Hydrophilic Interaction Chromatography/Mass Spectrometry", CHINESE JOURNAL OF PHARMACEUTICALS, SHANGHAI YIYAO GONGYE YANJIUYUAN,SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY, CN, vol. 49, no. 3, 30 March 2018 (2018-03-30), CN , pages 370 - 374, XP093075559, ISSN: 1001-8255, DOI: 10.16522/j.cnki.cjph.2018.03.016 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117074578A (en) * 2023-10-16 2023-11-17 瀚盟测试科技(天津)有限公司 LC-MS/MS quantitative detection method of 2- (methylamino) -ethanol
CN117074578B (en) * 2023-10-16 2024-02-09 瀚盟测试科技(天津)有限公司 LC-MS/MS quantitative detection method of 2- (methylamino) -ethanol

Also Published As

Publication number Publication date
CN117203524A (en) 2023-12-08

Similar Documents

Publication Publication Date Title
Wang et al. Solid phase microextraction combined with thermal-desorption electrospray ionization mass spectrometry for high-throughput pharmacokinetics assays
Magiera Fast, simultaneous quantification of three novel cardiac drugs in human urine by MEPS–UHPLC–MS/MS for therapeutic drug monitoring
CN106814150B (en) Isotope dilution ultra-performance liquid chromatography-mass spectrometry combined vitamin K determination method1Method (2)
CN113155992B (en) Method for simultaneously detecting concentration of aromatase inhibitor, phosphodiesterase type 5 inhibitor and metabolite of aromatase inhibitor in human plasma
CN108828077B (en) Kit for simultaneously detecting capecitabine and metabolite thereof in blood plasma as well as detection method and application thereof
Ni et al. Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study
Purgat et al. Determination of homocysteine thiolactone in human urine by capillary zone electrophoresis and single drop microextraction
CN112730706A (en) Method for detecting biological small molecule marker by liquid chromatography-tandem mass spectrometry
WO2023123309A1 (en) Method for measuring amino acid impurities in special solvent for butanedisulfonic acid adenosine methionine for injection
CN114674961A (en) Kit for synchronously detecting 17 steroid hormones in serum without derivatization and application thereof
Bhadoriya et al. Sensitive and rapid determination of amantadine without derivatization in human plasma by LC–MS/MS for a bioequivalence study
Guo et al. Measurement of tobramycin by reversed-phase high-performance liquid chromatography with mass spectrometry detection
CN113720946A (en) Method and kit for detecting multiple steroid hormones in blood
Said et al. High performance liquid chromatography–Mass spectrometric bioanalytical method for the determination of dapoxetine in human plasma: Application for bioequivalence study
Roiffé et al. Development of a sensitive and fast method for detection of catecholamines and metabolites by HRMS
Wang et al. Quantification of piperazine in chicken and pig tissues by gas chromatography–electron ionization tandem mass spectrometry employing pre-column derivatization with acetic anhydride
CN105092733B (en) The reduction method and apparatus of fixedness buffer salt content in LC MS testers
Leis et al. Synthesis of d1-N-ethyltramadol as an internal standard for the quantitative determination of tramadol in human plasma by gas chromatography–mass spectrometry
CN110361481A (en) Vancomycin monitor drug concentration kit and its detection method in a kind of blood
Abuín et al. Analysis of thyreostatic drugs in thyroid samples by ultra-performance liquid chromatography tandem mass spectrometry detection
CN110361482A (en) Linezolid monitor drug concentration kit and its detection method in a kind of blood
CN110361488A (en) Lamotrigine monitor drug concentration kit and its detection method in a kind of blood
CN110361485A (en) Oxcarbazepine monitor drug concentration kit and its detection method in a kind of blood
CN113030343B (en) Liquid chromatography tandem mass spectrometry detection method for pyrroloquinoline quinone in blood plasma
CN104991027B (en) The method for reducing fixedness buffer salt content in LC MS testers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21969666

Country of ref document: EP

Kind code of ref document: A1